Update on the safety and efficacy of teriparatide in the treatment of osteoporosis

Following the completion of the Fracture Prevention Trial, teriparatide was approved by the United States Food and Drug Administration and the European Medicine Agency as the first therapeutic anabolic agent for the treatment of postmenopausal women with severe osteoporosis. It subsequently received...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Musculoskelet Dis
Autors principals: Minisola, Salvatore, Cipriani, Cristiana, Grotta, Giada Della, Colangelo, Luciano, Occhiuto, Marco, Biondi, Piergianni, Sonato, Chiara, Vigna, Evelina, Cilli, Mirella, Pepe, Jessica
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6778993/
https://ncbi.nlm.nih.gov/pubmed/31632472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X19877994
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars